Presented at the International Society for CNS Clinical Trials and Methodology (ISCTM) Annual Scientific Meeting Virtual Edition, April 6-9, 2021

While episodic memory impairment is often the hallmark of mild cognitive impairment (MCI) due to Alzheimer’s disease (AD), impairment may also be observed in executive function, attention, language, and visuospatial skills. The aim of the present work is to assess the utility of the tablet-based BAC to identify and quantify episodic memory and other deficits in MCI due to AD.

View Poster